diabetes therapeutics (Metabolex/Abbott)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namediabetes therapeutics (Metabolex/Abbott)
Drug Alias Nameglucose transport signal transduction program (Metabolex/Abbott)GTST compounds (Metabolex/Abbott)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose transport modulators
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCymabay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesCymabay Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A